Texas Yale Capital Corp’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Hold |
70,000
| – | – | 0.01% | 456 |
|
|
2025
Q1 | $81.2K | Hold |
70,000
| – | – | ﹤0.01% | 443 |
|
|
2024
Q4 | $88.9K | Hold |
70,000
| – | – | ﹤0.01% | 453 |
|
|
2024
Q3 | $239K | Hold |
70,000
| – | – | 0.01% | 422 |
|
|
2024
Q2 | $327K | Hold |
70,000
| – | – | 0.02% | 364 |
|
|
2024
Q1 | $519K | Hold |
70,000
| – | – | 0.02% | 324 |
|
|
2023
Q4 | $709K | Hold |
70,000
| – | – | 0.03% | 284 |
|
|
2023
Q3 | $546K | Hold |
70,000
| – | – | 0.02% | 300 |
|
|
2023
Q2 | $576K | Hold |
70,000
| – | – | 0.03% | 298 |
|
|
2023
Q1 | $508K | Hold |
70,000
| – | – | 0.03% | 322 |
|
|
2022
Q4 | $621K | Hold |
70,000
| – | – | 0.04% | 301 |
|
|
2022
Q3 | $857K | Hold |
70,000
| – | – | 0.05% | 250 |
|
|
2022
Q2 | $828K | Buy |
70,000
+20,000
| +40% | +$237K | 0.05% | 254 |
|
|
2022
Q1 | $951K | Buy |
50,000
+10,000
| +25% | +$190K | 0.05% | 245 |
|
|
2021
Q4 | $1.06M | Buy |
40,000
+15,000
| +60% | +$398K | 0.05% | 241 |
|
|
2021
Q3 | $1.03M | Buy |
25,000
+5,000
| +25% | +$205K | 0.06% | 237 |
|
|
2021
Q2 | $1.13M | Hold |
20,000
| – | – | 0.06% | 225 |
|
|
2021
Q1 | $840K | Buy |
20,000
+10,000
| +100% | +$420K | 0.05% | 253 |
|
|
2020
Q4 | $701K | Buy |
+10,000
| New | +$701K | 0.05% | 275 |
|